Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.32 |
| ▸ | GUSB | P08236 | 3/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.31 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6417599 | 1.00 | MAOA (0.38) | MAOAMAOBATMABCB1GUSB | |
| SCHEMBL3370754 | 1.00 | MAOA (0.38) | MAOAMAOBATMABCB1GUSB | |
| SCHEMBL3370749 | 1.00 | MAOA (0.38) | MAOAMAOBATMABCB1GUSB | |
| SCHEMBL23894634 | 0.77 | MAOA (0.35) | MAOAMAOBATMABCB1 | |
| SCHEMBL3260378 | 0.77 | MAOA (0.35) | MAOAMAOBATM | |
| SCHEMBL25056919 | 0.77 | ABCB1 (0.44) | MAOAMAOBATMABCB1GUSB | |
| SCHEMBL312107 | 0.76 | ABCG2 (0.36) | MAOAMAOB | |
| SCHEMBL19885491 | 0.75 | MAOA (0.58) | MAOAMAOBATMHDAC3HDAC4 | |
| SCHEMBL11409097 | 0.74 | ABCB1 (0.35) | MAOAMAOBABCB1 | |
| SCHEMBL13551756 | 0.73 | ABCB1 (0.41) | MAOAMAOBABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1499618-B1 | FURYL COMPOUNDS | ASTRAZENECA AB (SE) | 2010-10-13 | — | — | EP | disclosed |
| US-7417049-B2 | Furyl compounds | ASTRAZENECA AB (SE) | 2008-08-26 | — | — | US | disclosed |
| US-20050176745-A1 | Furyl compounds | ASTRAZENECA AB (SE) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176745-A1 | Furyl compounds | AR, MC2R, CFTR | MAOA 624/4885MAOB 596/4885ATM 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.